Ropsohn Laboratorios

Ropsohn Laboratorios is a Colombian pharmaceutical company that specializes in the development, manufacturing, and commercialization of therapeutic products across several key medical specialties. Founded in 1972 and headquartered in Bogota, the company has built a strong reputation in the Andean region for its portfolio in dermatology, gynecology, pediatrics, and internal medicine. In early 2022, Ropsohn was acquired by the Brazilian pharmaceutical multinational Eurofarma, a move intended to strengthen Eurofarma's presence in the Colombian market and expand its regional manufacturing footprint. The company operates a certified production facility and maintains a robust distribution network for its branded generic medications.